CytoCan Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 3

CytoCan General Information

Description

Developer of modular platform technology to produce cancer cell-targeting proteins with multispecific functions. The company identifies unmet medical needs and difficult-to-treat cancers then designs targeted immune therapies by using its platform, providing multispecific proteins to help patients fight cancer.

Contact Information

Website
cytocan.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • A-603-1 Huarun Plaza
  • 1366 Qianjiang Road
  • Hangzhou, Zhejiang
  • China
+86 152
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • A-603-1 Huarun Plaza
  • 1366 Qianjiang Road
  • Hangzhou, Zhejiang
  • China
+86 152

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CytoCan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 07-Feb-2023 Completed Startup
To view CytoCan’s complete valuation and funding history, request access »

CytoCan Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bopu Capital Management Venture Capital Minority
Forcefield Venture Venture Capital Minority
XtalPi Technology Corporation Minority
To view CytoCan’s complete investors history, request access »

Ready to get started?

Request a free trial

CytoCan FAQs

  • When was CytoCan founded?

    CytoCan was founded in 2022.

  • Where is CytoCan headquartered?

    CytoCan is headquartered in Hangzhou, China.

  • What industry is CytoCan in?

    CytoCan’s primary industry is Drug Discovery.

  • Is CytoCan a private or public company?

    CytoCan is a Private company.

  • What is CytoCan’s current revenue?

    The current revenue for CytoCan is .

  • Who are CytoCan’s investors?

    Bopu Capital Management, Forcefield Venture, and XtalPi Technology have invested in CytoCan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process